🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/08/2010 | 6,03 | 6,29 | 5,95 | 6,25 | +3,09% | 5,59% | 60.914 |
| 17/08/2010 | 5,95 | 6,10 | 5,80 | 6,06 | +3,18% | 5,03% | 73.124 |
| 16/08/2010 | 5,65 | 5,88 | 5,65 | 5,88 | +3,29% | 3,97% | 57.895 |
| 13/08/2010 | 5,69 | 5,91 | 5,65 | 5,69 | -0,65% | 4,61% | 62.090 |
| 12/08/2010 | 5,73 | 5,91 | 5,73 | 5,73 | -1,29% | 3,27% | 41.411 |
| 11/08/2010 | 5,88 | 5,99 | 5,73 | 5,80 | -3,13% | 4,46% | 134.358 |
| 10/08/2010 | 5,99 | 6,10 | 5,95 | 5,99 | -0,62% | 2,50% | 50.788 |
| 09/08/2010 | 6,14 | 6,21 | 5,99 | 6,03 | -1,23% | 3,66% | 46.113 |
| 06/08/2010 | 6,03 | 6,14 | 5,91 | 6,10 | +0,00% | 3,73% | 36.148 |
| 05/08/2010 | 6,25 | 6,25 | 5,88 | 6,10 | -3,55% | 5,99% | 55.891 |
| 04/08/2010 | 6,29 | 6,33 | 6,18 | 6,33 | +1,20% | 2,38% | 54.582 |
| 03/08/2010 | 6,29 | 6,44 | 6,14 | 6,25 | +0,60% | 4,76% | 96.821 |
| 02/08/2010 | 6,25 | 6,25 | 5,99 | 6,21 | +0,61% | 4,19% | 53.460 |
| 30/07/2010 | 5,91 | 6,29 | 5,80 | 6,18 | +3,12% | 8,23% | 111.916 |
| 29/07/2010 | 6,03 | 6,10 | 5,80 | 5,99 | +0,63% | 4,97% | 26.156 |
| 28/07/2010 | 6,21 | 6,29 | 5,91 | 5,95 | -4,79% | 6,02% | 60.032 |
| 27/07/2010 | 6,18 | 6,29 | 6,10 | 6,25 | +1,21% | 3,03% | 101.443 |
| 26/07/2010 | 6,06 | 6,29 | 5,91 | 6,18 | +1,23% | 6,17% | 105.825 |
| 23/07/2010 | 5,73 | 6,10 | 5,58 | 6,10 | +5,84% | 9,15% | 109.512 |
| 22/07/2010 | 5,65 | 5,84 | 5,54 | 5,76 | +3,36% | 5,30% | 105.531 |
| 21/07/2010 | 5,65 | 5,91 | 5,46 | 5,58 | -0,67% | 7,95% | 93.722 |
| 20/07/2010 | 5,46 | 5,61 | 5,43 | 5,61 | +2,04% | 3,43% | 63.185 |
| 19/07/2010 | 5,43 | 5,65 | 5,43 | 5,50 | +1,38% | 4,14% | 48.651 |
| 16/07/2010 | 5,69 | 5,84 | 5,43 | 5,43 | -5,84% | 7,24% | 92.199 |
| 15/07/2010 | 6,03 | 6,06 | 5,69 | 5,76 | -4,35% | 6,21% | 66.070 |
| 14/07/2010 | 6,25 | 6,25 | 5,91 | 6,03 | -4,17% | 5,39% | 39.380 |
| 13/07/2010 | 5,73 | 6,29 | 5,61 | 6,29 | +12,00% | 11,76% | 146.300 |
| 12/07/2010 | 5,54 | 5,76 | 5,43 | 5,61 | +0,67% | 6,08% | 72.082 |
| 09/07/2010 | 5,65 | 5,65 | 5,46 | 5,58 | -1,33% | 3,31% | 49.185 |
| 08/07/2010 | 5,61 | 5,69 | 5,54 | 5,65 | +3,42% | 2,67% | 83.864 |